About Collidion
Collidion is a company based in Petaluma (United States) founded in 2015.. Collidion has raised $14.53 million across 3 funding rounds. Collidion has completed 1 acquisition, including Plex Pharmaceuticals. Collidion offers products and services including Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products. Collidion operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Petaluma, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Collidion Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.53 M (USD)
in 3 rounds
-
Latest Funding Round
$14.26 M (USD), Series A
Oct 30, 2019
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Collidion
Collidion offers a comprehensive portfolio of products and services, including Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops technologies for anti-infectives and disinfection to improve patient care.
Focuses on treatments for diseases like Parkinson's and cataracts.
Creates products for sterilization and consumer health applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Collidion
Collidion has successfully raised a total of $14.53M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $14.26 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $14.3M
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series A - Collidion | Valuation |
investors |
|
| Apr, 2019 | Amount | Debt – Conventional - Collidion | Valuation |
investors |
|
| Apr, 2019 | Amount | Series A - Collidion | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Collidion
Collidion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Plex Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Discovering small molecules for diseases caused by protein misfolding such as Parkinson's.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Collidion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Collidion Comparisons
Competitors of Collidion
Collidion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Collidion
When was Collidion founded?
Collidion was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Where is Collidion located?
Collidion is headquartered in Petaluma, United States. It is registered at Petaluma, California, United States.
Is Collidion a funded company?
Collidion is a funded company, having raised a total of $14.53M across 3 funding rounds to date.
What does Collidion do?
Collidion Inc. was founded in 2015 and is headquartered in Petaluma, United States. Operations center on the healthcare sector, where early-stage ideas and research are identified and licensed for advancement into commercial products. Emphasis is given to combating antibiotic resistance, developing drugs against biofilms, and creating delivery systems for both systemic and topical applications.
Who are the top competitors of Collidion?
Collidion's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Collidion offer?
Collidion offers Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products.
How many acquisitions has Collidion made?
Collidion has made 1 acquisition, including Plex Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.